Erdafitinib inhibits the tumorigenicity of MDA-MB-231 triple-negative breast cancer cells by inducing TRIM25/ubiquitin-dependent degradation of FGFR4.

Detalles Bibliográficos
Publicado en:	Breast Cancer Research Vol. 27; no. 1; pp. 1 - 18
Autores principales:	Luo, Qing, Zhang, Li, Hao, Yue, Xu, Chunwei, Wang, Xiaojia, Jia, Zhen, Xie, Xiandong, Huang, Zhihong, Gao, Xiaomin, Chen, Yu, Zhu, Xue, Fang, Jing, Wang, Ke, Yin, Yongxiang
Formato:	Journal Article
Publicado:	BioMed Central 7/9/2025
Acceso en línea:	Ver este registro en EBSCOhost

Internet